Literature DB >> 17115030

The armadillo protein p0071 regulates Rho signalling during cytokinesis.

Annika Wolf1, Rene Keil, Oliver Götzl, Andrej Mun, Katrin Schwarze, Marcell Lederer, Stefan Hüttelmaier, Mechthild Hatzfeld.   

Abstract

Cytokinesis requires the spatio-temporal coordination of cell-cycle control and cytoskeletal reorganization. Members of the Rho-family of GTPases are crucial regulators of this process and assembly of the contractile ring depends on local activation of Rho signalling. Here, we show that the armadillo protein p0071, unlike its relative p120(ctn), is localized at the midbody during cytokinesis and is essential for cell division. Both knockdown and overexpression of p0071 interfered with normal cell growth and survival due to cytokinesis defects with formation of multinucleated cells and induction of apoptosis. This failure of cytokinesis seemingly correlated with the deregulation of Rho activity in response to altered p0071 expression. The function of p0071 in regulating Rho activity occurred through an association of p0071 with RhoA, as well as the physical and functional interaction of p0071 with Ect2, the one Rho guanine-nucleotide exchange factor (GEF) essential for cytokinesis. These findings support an essential role for p0071 in spatially regulating restricted Rho signalling during cytokinesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17115030     DOI: 10.1038/ncb1504

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  32 in total

Review 1.  Understanding cytokinesis failure.

Authors:  Guillaume Normand; Randall W King
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 2.  The catenin family at a glance.

Authors:  Pierre D McCrea; Dongmin Gu
Journal:  J Cell Sci       Date:  2010-03-01       Impact factor: 5.285

3.  Shared molecular mechanisms regulate multiple catenin proteins: canonical Wnt signals and components modulate p120-catenin isoform-1 and additional p120 subfamily members.

Authors:  Ji Yeon Hong; Jae-Il Park; Kyucheol Cho; Dongmin Gu; Hong Ji; Steven E Artandi; Pierre D McCrea
Journal:  J Cell Sci       Date:  2010-11-23       Impact factor: 5.285

Review 4.  Anchoring junctions as drug targets: role in contraceptive development.

Authors:  Dolores D Mruk; Bruno Silvestrini; C Yan Cheng
Journal:  Pharmacol Rev       Date:  2008-05-15       Impact factor: 25.468

5.  Loss of p120 catenin and links to mitotic alterations, inflammation, and skin cancer.

Authors:  Mirna Perez-Moreno; Weimin Song; H Amalia Pasolli; Scott E Williams; Elaine Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-22       Impact factor: 11.205

6.  microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest.

Authors:  Zhenze Zhao; Xiuye Ma; Derek Sung; Monica Li; Adam Kosti; Gregory Lin; Yidong Chen; Alexander Pertsemlidis; Tzu-Hung Hsiao; Liqin Du
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

7.  Protein p0071, an armadillo plaque protein of adherens junctions, is predominantly expressed in distal renal tubules.

Authors:  Britta Walter; Ulrike Krebs; Irina Berger; Ilse Hofmann
Journal:  Histochem Cell Biol       Date:  2009-10-15       Impact factor: 4.304

8.  Plakophilin 1 stimulates translation by promoting eIF4A1 activity.

Authors:  Annika Wolf; Malgorzata Krause-Gruszczynska; Olaf Birkenmeier; Antje Ostareck-Lederer; Stefan Hüttelmaier; Mechthild Hatzfeld
Journal:  J Cell Biol       Date:  2010-02-15       Impact factor: 10.539

9.  RhoA and RhoC are both required for the ROCK II-dependent promotion of centrosome duplication.

Authors:  M Kanai; M S Crowe; Y Zheng; G F Vande Woude; K Fukasawa
Journal:  Oncogene       Date:  2010-08-09       Impact factor: 9.867

Review 10.  p120 catenin: an essential regulator of cadherin stability, adhesion-induced signaling, and cancer progression.

Authors:  Antonis Kourtidis; Siu P Ngok; Panos Z Anastasiadis
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.